Effect of multiple mutations in the core promoter and pre-core/core region of hepatitis B virus genome on the response to interferon in e antigen-positive chronic hepatitis B-Reference-Cited by-同舟云学术

Effect of multiple mutations in the core promoter and pre-core/core region of hepatitis B virus genome on the response to interferon in e antigen-positive chronic hepatitis B

Published:2001-04 Issue:4 Volume:16 Page:393-398
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:J Gastroenterol Hepatol

Author:

Zhang Xinxin,Han Yongnian,Lu Zhimeng,Gao Jian,Luo Zhenghui,Zhang Donghua

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1440-1746.2001.02451.x/fullpdf

Reference37 articles.

1. Treatment of chronic hepatitis B virus infection: An Asia–Pacific perspective

2. Interferon treatment in patients with chronic hepatitis B: A meta-analysis of the published literature

3. To treat or not to treat?

4. Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B

5. Hepatitis B Virus Mutants

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis B Virus Precore Protein p22 Inhibits Alpha Interferon Signaling by Blocking STAT Nuclear Translocation;Journal of Virology;2019-07

2. Low pretreatment serum HBsAg level and viral mutations as predictors of response to PEG-interferon alpha-2b therapy in chronic hepatitis B;Journal of Clinical Virology;2009-10

3. Association study of IFNAR2 and IL10RB genes with the susceptibility and interferon response in HBV infection;Journal of Viral Hepatitis;2009-09

4. Negative effect of IFN-α2b against HBV-DNA in PBMC, serum and inducement to CD25 in the patients with chronic hepatitis B;2009 IEEE International Symposium on IT in Medicine & Education;2009-08

5. A Systematic Review of T-cell Epitopes in Hepatitis B Virus: Identification, Genotypic Variation and Relevance to Antiviral Therapeutics;Antiviral Therapy;2008-02